Zognition, LLC

Zognition manufactures ZogniQ™ ZPL (Polarized Light), a patent-pending advancement in low-level light therapy (LLLT) designed for non-invasive, targeted wellness applications. The device harnesses proprietary polarized light technology across multiple wavelengths (red, blue, yellow, infrared) to support cellular regeneration, reduce inflammation, and alleviate pain. Engineered by a team with 60+ years of combined medical, scientific, and device engineering expertise, ZogniQ™ emphasizes precision control, consistency, and repeatable outcomes. Features include configurable multi-wavelength settings, 8K pre/post-session imaging for visual documentation, real-time proximity monitoring via infrared time-of-flight sensors, and a 15.6" touchscreen interface. The platform is designed for integration into modern wellness, dermatology, ophthalmology, and aesthetic medicine practices, offering clinicians a scientifically-grounded, evidence-based solution for light-based therapeutic interventions with emphasis on safety, user comfort, and long-term scalability.